Menigococcus vaccine containing lipooligosaccharide (LOS) from modified strains of L6 immunotype

Details for Australian Patent Application No. 2010247254 (hide)

Owner Sanofi Pasteur

Inventors Mistretta, Noelle; Moreau, Monique; Renauld-Mongenie, Genevieve; Rokbi, Bachra

Agent Davies Collison Cave

Pub. Number AU-A-2010247254

PCT Pub. Number WO2010/130898

Priority 61/271,986 29.07.09 US; 0902333 14.05.09 FR

Filing date 12 May 2010

Wipo publication date 18 November 2010

International Classifications

A61K 39/095 (2006.01) Medicinal preparations containing antigens or antibodies - Neisseria

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 15/63 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using vectors

Event Publications

12 January 2012 PCT application entered the National Phase

  PCT publication WO2010/130898 Priority application(s): WO2010/130898

16 February 2012 Corrigenda

  PCT applications that have entered the National Phase - Name Index Under the name Sanofi Pasteur, Application No. 2010247254, under INID (54) correct the title to Menigococcus vaccine containing lipooligosaccharide (LOS) from modified strains of L6 immunotype Neisseria meningitidis

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010247255-Meningococcal vaccine based on lipooligosaccharide (LOS) and Neisseria meningitidis protein

2010247253-Method for detoxification of lipopolysaccharide (LPS) or of lipid a of gramnegative bacteria